Selected article for: "cancer cell and development growth"
Author: Evans, Jilly Frances; Obraztsova, Kseniya; Lin, Susan M.; Krymskaya, Vera P.
Title: CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
  • Cord-id: osmc7x39
  • Document date: 2021_2_24
    • ID: osmc7x39
    Snippet: The mechanistic target of rapamycin (mTOR) and wingless-related integration site (Wnt) signal transduction networks are evolutionarily conserved mammalian growth and cellular development networks. Most cells express many of the proteins in both pathways, and this review will briefly describe only the key proteins and their intra- and extracellular crosstalk. These complex interactions will be discussed in relation to cancer development, drug resistance, and stem cell exhaustion. This review will
    Document: The mechanistic target of rapamycin (mTOR) and wingless-related integration site (Wnt) signal transduction networks are evolutionarily conserved mammalian growth and cellular development networks. Most cells express many of the proteins in both pathways, and this review will briefly describe only the key proteins and their intra- and extracellular crosstalk. These complex interactions will be discussed in relation to cancer development, drug resistance, and stem cell exhaustion. This review will also highlight the tumor-suppressive tuberous sclerosis complex (TSC) mutated, mTOR-hyperactive lung disease of women, lymphangioleiomyomatosis (LAM). We will summarize recent advances in the targeting of these pathways by monotherapy or combination therapy, as well as future potential treatments.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and acute myeloid leukemia: 1, 2, 3, 4, 5
    • action mechanism and adaptive design: 1
    • action mechanism and adcs antibody drug conjugate: 1
    • action mechanism and liver cancer: 1
    • action mechanism and low concentration: 1, 2, 3, 4
    • action mechanism and low density: 1, 2, 3, 4
    • action mechanism and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action mechanism and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action mechanism and lung function: 1, 2, 3, 4, 5, 6, 7
    • action mechanism and lung mesenchymal: 1
    • action mechanism and lung reduce: 1, 2, 3, 4, 5, 6, 7